183 related articles for article (PubMed ID: 13443)
21. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
Kolivakis T; Azim H; Kingstone E
Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
[No Abstract] [Full Text] [Related]
22. [Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model].
Gaebel W; Pietzcker A
Nervenarzt; 1983 Sep; 54(9):467-76. PubMed ID: 6138719
[No Abstract] [Full Text] [Related]
23. Results obtained with Orap in the therapy of neuropsychiatric outpatients.
Perényi G; Várkonyi B+VARKONYI B
Ther Hung; 1974; 22(2):65-8. PubMed ID: 4608508
[No Abstract] [Full Text] [Related]
24. [Effects of TPN-12 Sandoz in schizophrenia].
Pogorzelski W; Rogiewicz A; Wojdyslawska I
Psychiatr Pol; 1973; 7(1):65-8. PubMed ID: 4715834
[No Abstract] [Full Text] [Related]
25. Effects of pimozide on the psychopathology of delusional disorder.
Silva H; Jerez S; Ramirez A; Renteria P; Aravena N; Salazar D; Labarca R
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb; 22(2):331-40. PubMed ID: 9608605
[TBL] [Abstract][Full Text] [Related]
26. Histochemical changes in the blood cells of schizophrenic patients under pimozide treatment.
Stefanis CN; Issidorides MR
Biol Psychiatry; 1976 Feb; 11(1):53-68. PubMed ID: 769850
[TBL] [Abstract][Full Text] [Related]
27. Specific indications for different classes of phenothiazines.
Hollister LE; Overall JE; Kimbell I; Pokorny A
Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
[No Abstract] [Full Text] [Related]
28. Huntington's disease masquerading as chronic schizophrenia.
Van Putten T; Menkes JH
Dis Nerv Syst; 1973 Jan; 34(1):54-6. PubMed ID: 4145383
[No Abstract] [Full Text] [Related]
29. Pimozide and the social behavior of schizophrenics.
Lapierre YD; Lavallee J
Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
[No Abstract] [Full Text] [Related]
30. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
Ban TA; Ananth JV; Lehmann HE
Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
[No Abstract] [Full Text] [Related]
31. A preliminary study of SKF-14,336 in chronic schizophrenia.
Simpson GM; Iqbal J; Iqbal F
Curr Ther Res Clin Exp; 1966 Sep; 8(9):447-51. PubMed ID: 4957931
[No Abstract] [Full Text] [Related]
32. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
Cassan P
Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
[No Abstract] [Full Text] [Related]
33. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
Donlon PT; Rada RT
Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and statistical evaluation of neuroleptic pimozide].
Glatzel J
Int Pharmacopsychiatry; 1971; 6(1):60-6. PubMed ID: 5163169
[No Abstract] [Full Text] [Related]
35. A preliminary approach to the problems of relating the pharmacokinetics of phenothiazines to clinical response with schizophrenic patients [proceedings].
Gottschalk LA
Psychopharmacol Bull; 1978 Jul; 14(3):35-9. PubMed ID: 27839
[No Abstract] [Full Text] [Related]
36. An open study with a new long-acting neuroleptic.
Fleischhauer J; Angst J; Padrutt A; Vetter P
Act Nerv Super (Praha); 1973 May; 15(2):85-6. PubMed ID: 4752678
[No Abstract] [Full Text] [Related]
37. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
Amin MM; Ban TA; Lehmann HE
Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
[No Abstract] [Full Text] [Related]
38. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
Gross HS
Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
[No Abstract] [Full Text] [Related]
39. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
Vergara L; Amin MM; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
[No Abstract] [Full Text] [Related]
40. Clinical trial of ORAP in schizophrenia.
Mrna B; Klima V; Koupil M; Komenda S
Act Nerv Super (Praha); 1975 Sep; 17(3):204-5. PubMed ID: 1106105
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
